User:Crusher123/Kalos Therapeutics

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs
This page was last edited by Cydebot (talk | contribs) 5 years ago. (Update timer)

Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Submit your draft for review!

Kalos Therapeutics is a biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer. ^[1]

Kalos has been covered by ABC News ^[2] on Good Morning America, and profiled in Business Week. ^[3] The company aggressively targets diseases caused by an abnormally high growth rate of cells (hyper proliferation), ^[4] and is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.^[5]

References[edit]

External Links

[1] Business Week Article

[2] GMA

[3] ABC News

[4] Drugs.com Article

[5] Kalos website

[1]

[2]

[3]

[4]

[5]